Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Humana Inc (NYSE: HUM) closed at $257.68 down -0.66% from its previous closing price of $259.4. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 1.09 million shares were traded. HUM stock price reached its highest trading level at $263.0 during the session, while it also had its lowest trading level at $256.0176.
Ratios:
For a deeper understanding of Humana Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.68.
On October 14, 2025, Goldman started tracking the stock assigning a Sell rating and target price of $235.
On September 22, 2025, Evercore ISI started tracking the stock assigning a In-line rating and target price of $295.Evercore ISI initiated its In-line rating on September 22, 2025, with a $295 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 30991964160 and an Enterprise Value of 21876963328. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.15, and their Forward P/E ratio for the next fiscal year is 20.97. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 1.67. Its current Enterprise Value per Revenue stands at 0.173 whereas that against EBITDA is 5.666.
Stock Price History:
The Beta on a monthly basis for HUM is 0.45, which has changed by 0.01518476 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $315.35, while it has fallen to a 52-week low of $206.87. The 50-Day Moving Average of the stock is -0.76%, while the 200-Day Moving Average is calculated to be -0.36%.
Shares Statistics:
For the past three months, HUM has traded an average of 1.76M shares per day and 1560520 over the past ten days. A total of 120.27M shares are outstanding, with a floating share count of 120.00M. Insiders hold about 0.23% of the company’s shares, while institutions hold 96.81% stake in the company. Shares short for HUM as of 1764288000 were 4784843 with a Short Ratio of 2.71, compared to 1761868800 on 3876253. Therefore, it implies a Short% of Shares Outstanding of 4784843 and a Short% of Float of 4.46.
Dividends & Splits
According to the company, the forward annual dividend rate for HUM is 3.54, from 3.54 in the trailing year. Against a Trailing Annual Dividend Yield of 0.013646877. The stock’s 5-year Average Dividend Yield is 0.86. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-12-26. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The stock of Humana Inc (HUM) is currently in the spotlight, with 24.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $10.64, with high estimates of $13.1 and low estimates of $6.23.
Analysts are recommending an EPS of between $17.57 and $16.57 for the fiscal current year, implying an average EPS of $17.05. EPS for the following year is $12.45, with 26.0 analysts recommending between $14.41 and $9.83.
Revenue Estimates
A total of 18 analysts believe the company’s revenue will be $32.07B this quarter.It ranges from a high estimate of $32.39B to a low estimate of $31.65B. As of. The current estimate, Humana Inc’s year-ago sales were $29.21BFor the next quarter, 18 analysts are estimating revenue of $35.44B. There is a high estimate of $40.65B for the next quarter, whereas the lowest estimate is $34.34B.
A total of 20 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $129.54B, while the lowest revenue estimate was $128.65B, resulting in an average revenue estimate of $129.17B. In the same quarter a year ago, actual revenue was $117.76BBased on 20 analysts’ estimates, the company’s revenue will be $143.92B in the next fiscal year. The high estimate is $163.93B and the low estimate is $137.08B.
